Invention Grant
- Patent Title: Humanized antibodies against TL1A
- Patent Title (中): 针对TL1A的人源化抗体
-
Application No.: US13585792Application Date: 2012-08-14
-
Publication No.: US08728482B2Publication Date: 2014-05-20
- Inventor: Rodger Smith , Palanisamy Kanakaraj , Viktor Roschke , Craig Rosen , Bridget A. Cooksey
- Applicant: Rodger Smith , Palanisamy Kanakaraj , Viktor Roschke , Craig Rosen , Bridget A. Cooksey
- Applicant Address: US MD Rockville
- Assignee: TEVA Biopharmaceuticals USA, Inc.
- Current Assignee: TEVA Biopharmaceuticals USA, Inc.
- Current Assignee Address: US MD Rockville
- Agency: Foley & Lardner LLP
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
Disclosed are humanized antibodies that bind specifically to TNF superfamily member 15 (TNFSF15), also known as TL1A. Methods of making and using the anti-TL1A antibodies are also described. The humanized antibodies may be antagonists and may used to treat or diagnose conditions associated with TL1A function.
Public/Granted literature
- US20120308480A1 HUMANIZED ANTIBODIES AGAINST TL1A Public/Granted day:2012-12-06
Information query
